| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-10 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.24 | 4e-07 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |